abbott laboratories - Search News

Abbott Recovers

Abbott's first-quarter profit forecast misses estimates, shares dip

Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics units overshadowed strength in medical devices, sending its shares down more than 2% in premarket trading.

Bloomberg on MSN · 1d

Abbott Recovers After First-Quarter Outlook Misses Estimates

Abbott Laboratories is forecasting lower-than-expected first-quarter earnings but full-year profit in line with Wall Street estimates as the health care company points to strong demand for its medical devices as a growth driver this year.

Business Insider · 1d

Abbott Laboratories Q4 Profit Increases, Inline With Estimates

Abbott Laboratories (ABT) revealed a profit for its fourth quarter that increased from last year in line with the Street estimates.

Abbott Laboratories: Now Back In The Buy Zone (Rating Upgrade)

Abbott Laboratories just extended its dividend growth streak with a 7.3% hike in the quarterly dividend per share last month.

Abbott Laboratories: Solid Performance in Key Sectors but Hold Rating Due to Mixed Outlook

Morgan Stanley analyst Patrick Wood maintained a Hold rating on Abbott Laboratories (ABT – Research Report) yesterday and set a price target of ...

Hosted on MSN11h

Abbott Laboratories Reports Strong 2024 Financial Results

Abbott Laboratories ( ($ABT) ) has released its Q4 earnings. Here is a breakdown of the information Abbott Laboratories ...

3hon MSN

Abbott banks on glucose monitors, new launches to ride out China, currency hit

Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device ...

23h

Abbott Laboratories’ Growth Prospects and Market Leadership in MedTech Justify Buy Rating

BTIG analyst Marie Thibault maintained a Buy rating on Abbott Laboratories (ABT – Research Report) today and set a price target of ...

Abbott Labs 4Q Sales Underwhelm Amid Diminished Demand for Covid-19 Related Sales

For full-year 2025, the company forecast organic sales growth between 7.5% and 8.5% as well as adjusted earnings per share in the range of $5.05 and $5.25. Analysts polled by FactSet expect $42 ...

Investor's Business Daily on MSN21h

Abbott Shrugs Off 'Middling' Quarter As 2025 Sales Guidance, Diabetes Tech Shine

Abbott stock reversed early losses Wednesday on its strong sales outlook for 2025 and a bullish performance from its diabetes ...

Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall

Abbott's Q4 sales reached $10.97 billion, with 8.8% organic growth. EPS met expectations at $1.34, driven by strong ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Abbott Recovers

Related topics